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Received 9 December 2015; revised 21 December 2015; accepted 24 December 2015AbstractObjective: To identify presence of inflammasome activated in mouse cochlea with sensorineural hearing loss (SNHL) caused by cytomegalovirus
(CMV) infection.
Method: MCMV was injected into the right cerebral hemisphere in neonatal BALB/c mice at 2000 pfu virus titers. Auditory brainstem responses
(ABRs) were tested to evaluate hearing at 21 days. Histopathological studies were conducted to confirm localizations ofMCMVinfected cells in the
inner ear. Expression of inflammasome related factors was assessed by immunofluorescence, Quantitative real-time PCR and Western blotting.
Results: In the mouse model of CMV induced SNHL, inflammasome related kinase Caspase-1 and downstream inflammatory factor IL-1b and
IL-18 were found increased and activated after CMV infection in the cochlea. These factors could further up-regulate expression of IL-6 and
TNF-a. These inflammatory factors are neurotoxicity and may contribute to hearing impairment. Furthermore, we also detected significantly
increased AIM2 protein that accumulated in the SGN of cochleae with CMV infection.
Significance: We have shown that inflammasome as a novel inherent immunity mechanism may contribute to hearing impairment.
Conclusion: Our data indicate that imflammasome assemble in mouse inner ear in response to CMV infection. We have revealed a novel pa-
thology event in CMV induced SNHL involving activation of inflammasome in mouse cochlea. Additionally, we have shown that inflammasome
may be a novel target for prevention and treatment of CMV related SNHL.
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Congenital cytomegalovirus (CMV) infection is the leading
cause of non-hereditary congenital sensorineural hearing loss
(SNHL) (Wang et al., 2013; Ikuta et al., 2015). Previous studies
have showed that most congenital CMV infections are asymp-
tomatic, and only 30% of infections are symptomatic at birth
(Koyano et al., 2011). SNHL occurs both in symptomatic and
asymptomatic CMV infections (Dahle et al., 2000, 1974). It is
difficult to prevent congenital CMV induced SNHL through
newborn hearing screening (Korver et al., 2009), and treatmentgapore) Pte Ltd On behalf of PLA General Hospital Department of Otolaryn-
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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also failed (Dahle et al., 2000; Fowler, 2013).
Recent studies show that inflammation induced by CMV
infection impairs the sensorineural hearing system, which
gives a light to understanding the pathology of CMV
related SNHL (Schachtele et al., 2011). However, mecha-
nisms and key events regarding how CMV initiates/ignites
the inflammation process in the inner ear remains
unknown.
The inflammasome is a multiprotein oligomer consisting
of caspase 1, PYCARD and the pattern recognition receptors
(PRRs) expressed in myeloid cells and is a component of the
innate immune system (Martinon et al., 2002). The PPRs
initiates inflammasome assembly and determines the exact
composition of an inflammasome (Takeuchi and Akira,
2010). A number of inflammasome-forming PRRs have
been identified, including the NLR family, pyrin domain
containing 1 (NLRP1), NLRP3, NLRP6, NLRP7, NLRP12,
CARD domain containing 4 (NLRC4), AIM 2 (absent in
melanoma 2), IFI16 and RIG-I (Latz et al., 2013). AIM2
plays an important role in the defense against viral infections
(Schroder et al., 2009), particularly in CMV. AIM2 can bind
to transfected or pathogen-derived cytoplasmic dsDNA and
subsequently recruits Asc by PYDePYD interaction, which,
in turn, binds caspase-1 (Sollberger et al., 2014). The cas-
pase1 is activated in assembling inflammasome and further
promotes the maturation the inflammatory cytokines Inter-
leukin 1b (IL-1b) and Interleukin 18 (IL-18), which are some
of the earliest and most important alarms to infection
(LaRock et al., 2015).
In this study, we reveal a new pathology event in CMV
induced SNHL through the activation of inflammasome in
mouse cochlea. We further confirm that the DNA sensor AIM2
protein is responsible for CMV activated inflammasome
assembling and subsequent ignition of inflammation in the
whole inner ear. Our study gives a reasonable interpretation on
how CMV initiates inflammation in the inner ear and ulti-
mately induces hearing loss.
2. Material and method2.1. Virus and animal modelMCMV (Smith strain) was kindly provided by HongMeng
of Shandong University. MCMV was replicated in NIH3T3
cells cultured with Dulbecco's modified Eagle's medium
(DMEM, gibbco) containing 10% fetal calf serum, strepto-
mycin (300 g/ml) and penicillin (300 U/ml). The supernatant
from the MCMV infected NIH3T3 cells was centrifuged at
1600  g for 10 min, and stored as aliquots at 80 C until
use. MCMV was injected into the right cerebral hemisphere of
neonatal (within 24 h old) BALB/c mice using 2000 pfu virus
titers, with DMEM as mocking injection. Animal experiments
were performed in accordance with a protocol approved by the
Ethics Committee of the Experimental Animal Center at
Xuzhou Medical University.2.2. Evaluation of hearing lossHearing loss was evaluated at 3 weeks of age by measuring
the auditory brainstem responses (ABRs). Anesthesia was
induced with pentobarbital sodium. Click stimuli were
generated. ABR waveforms were recorded in 10 dB intervals
down from 90 dB SPL until no waveforms could be visualized
(thresholds).2.3. Histopathological studiesMice were exsanguinated by transcardial perfusion with
phosphate-buffered saline (PBS) and then fixed with 4%
paraformaldehyde in phosphate buffer (4% PFA-PB). The
Cochlea was dissected away from the skull and immersed in
4% PFA-PB overnight, and decalcified with 100 mM EDTA in
PBS for 2 days at 25 C. The cochlea was then embedded in
paraffin blocks. Cochlear sections were cut and mounted on
poly-l-lysin-coated glass slides, and stained with anti-MCMV
pp89 encoded by MCMV IE-1 as described previously
(Koontz et al., 2008). Decalcified cochleae were embedded in
low melting point paraplast and sliced into 6-m m sections,
followed by overnight incubation at 4 C with one of the
following primary antibodies: Caspase-1 (ab1872, Abcam) or
AIM2 (ab76423, Abcam). Negative controls were prepared in
parallel under identical conditions but incubated without pri-
mary antibodies. Sections were washed thrice in PBS and
incubated with a corresponding secondary antibody (Alexa
Fluor 488 or 594, IgG, Thermofisher) diluted in PBS for 1 h.
Nuclei were counterstained with DAPI (Invitrogen). Images of
immunolabeled specimens were obtained by confocal fluo-
rescence microscopy.2.4. Quantitative real-time PCRThe total RNA of mouse cochlea was extracted using Trizol
reagent according to the manufacturer's protocol (TIANGEN).
Complementary DNA (cDNA) was synthesized from 1 mg of
total RNA using the ImProm-II TM Reverse Transcription
System (Promega, USA). To assess possible gene amplifica-
tion, quantitative RT-PCR was done using SYBR green
chemistry. b-actin as internal standard was arbitrarily assigned
a value of 1.0. The sequence-specific primers in quantitative
RT-PCR were indicated as follows: IL-6: F: CTGCAAGA-
GACTTCCATCCAG, R: AGTGGTATAGACAGGTCTGT
TGG; TNF-a: F: CTTCTCATTCCTGCTTGTGG, R: CACT
TGGTGGTTTGCTACG; IL1b: F: GAAATGCCACCTTTT-
GACAGTG, R: TGGATGCTCTCATCAGGACAG; AIM2: F:
GGTAAAGGAAGGCAGTGAG, R: GACATTGAGGGT-
GAAGTAGG; Actin: F: CTGAGAGGGAAATCGTGCGT, R:
AACCGCTCGTTGCCAATAGT.2.5. Western blottingTissue from mouse cochlea was lysed by RIPA. Western
blotting was performed as described previously (Wang et al.,
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onto an PVDF membrane (Millipore, Bedford, MA). Blots
were then immunoreacted with anti-Caspase1 (ab1872,
Abcam), IL18 (ab71495, Abcam), and AIM2 (ab76423,
Abcam), diluted in 5% skim milk, and protein bands were
visualized using a chemiluminescence detection system ECL
plus (GE Healthcare). Signals in the immunoblots were
analyzed through exposure on picture.
3. Results3.1. CMV infection in cochlea and SNHLTo establish the model of CMV induced SNHL, neonatal
Balb/c mice were injected in the right cerebral lobe with either
medium or the RM461 strain of MCMV. At 21 d post infec-
tion, the age when mouse auditory thresholds are considered
mature (Ikuta et al., 2015), both control and MCMV-infected
mice were tested for the presence of auditory brainstem re-
sponses (ABRs) (Table S1 for details). Fig. 1A shows a
significantly increased ABR threshold in a CMV infected
mouse compared with a control. Immunohistochemistry using
IE-1 as a MCMV marker showed that SGN and SV were sites
of viral infection (Fig. 1B).3.2. Cochlear inflammation with CMV infectionInflammation plays a pivotal role in CMV-induced SNHL
that has been described in many previous studies (SchachteleFig. 1. Inner ear images and SNHL in a CMV infected mouse. A, CMV induced
showing the localization of CMV in SV (left) and SGN (right) in the cochlea. Scaet al., 2011; Wong and Ryan, 2015). Changes of inflamma-
tory factors were detected in this study via Quantitative real-
time PCR. Fig. 2 shows significant up-regulation of IL-6,
TNF-a and especially IL-1b along with CMV infection in
mouse inner ear.3.3. Assembling inflammasome in cochlea in response to
CMV infectionFollowing detection of increasing mRNA levels of IL-1b by
Q-PCR, we next intended to determine whether Caspase-1, an
upstream kinase for the activation of IL-1b, was responsive to
CMV infection in mouse cochlea. Data showed that Caspase-1
was notably up-regulated at both mRNA (Fig. 3A) and pro-
teins level (Fig. 3B) during CMV-induced SNHL. Increased
Caspase-1 mainly localized in SGN cells by immunofluores-
cence data (Fig. 3C). Moreover, cleaved Caspase-1 and IL-18,
another substrate of Caspase-1, was also detected in CMV
infected cochleae (Fig. 3B), indicating that inflammasome was
activated and played an important role in triggering the
inflammation during MCMV-induced SNHL.3.4. AIM2 as a key regulator for assembling
inflammasome during CMV-induced SNHLIncreased AIM2 regulating caspase-1-dependent matura-
tion of IL-1b and IL-18 in response to cytosolic double-
stranded DNA from CMV infection (Guerville et al., 2015)
was detected by Q-PCR and west blot (Figs. 4A and B),hearing loss detected by ABR thresholds. B, Immunohistochemisty of IE-1
le bar: 50 mm.
Fig. 2. CMV induced inflammation in mouse inner ear. Increased inflammatory factors including IL-6 (A), TNF-a (B) and IL-1b (C) in mouse cochlea induced by
CMV infection.
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similar with a previous study that confirmed Aim2 as an
important anti-microbial sensor and a key determinant of
protective immunity to viral pathogens (Rathinam et al.,
2010).
4. Discussion
In this study, we found CMV positive cells mainly in the
SV and SGN cells in CMV infected mouse cochleae (Fig. 1B).
This is similar with the colonization of CMV in the humanFig. 3. Inflammasome activation in mouse inner ear after CMV infection. A. Up-re
and downstream factor IL-18 detected by WB. C. Immunofluorescence showing ininner ear (Teissier et al., 2011). Moreover, CMV related
inflammation also has been detected both in our model (Fig. 2)
and in other studies (Harari et al., 2004). Inflammation is a key
component of the immune response during infections with
different pathogenic microorganisms. Inflammation can be
protective by preventing microorganism colonization, repli-
cation, invasion, and dissemination. Insufficient inflammation
commonly leads to increased susceptibility to infection or
prolonged disease. Conversely, excessive inflammation is a
driver of several autoimmune diseases and host tissue injury,
complicating infectious diseases. Inflammation must thereforegulated mRNA level of Caspase-1 detected by Q-PCR. B. Cleaved Caspase-1
creased Caspase-1 in SGN. Scale bar: 20 mm.
Fig. 4. AIM2 responsible for Inflammasome activation in mouse inner ear after CMV infection. A. Up-regulated mRNA level of AIM2 detected by Q-PCR. B. Up-
regulated AIM2 detected by WB. C. Immunofluorescence showing increased AIM2 in SGN. Scale bar: 20 mm.
Fig. 5. A diagram of possible pathways about CMV induced SNHL.
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However, pathogens usually can exploit the regulatory pro-
cesses deployed by the host innate immune system to inter-
mediate propagation and invasion (LaRock et al., 2015). For
example, inflammation helps break down the bloodebrain
barrier (BBB) to cause meningitis (Spindler and Hsu, 2012).
This phenomenon is consisted with our previous study on
LPS helping CMV invade the nervous system (data not
shown).
In addition, CMV infected cells discharge/secrete different
factors to recruit T-cells and macrophages to eliminate virus
infected cells, which can result in neurotoxicity to periphery
and central nervous system (Guerville et al., 2015). These
observations indicate that inflammation may result in tissue
damage and lead to acute complications independent of CMV
itself. Thus, even if the pathogen is successfully cleared, the
process can be associated with post-infectious sequelae.
Therefore, blocking excessive inflammation resulting from
CMV infection is important for prevention against CMV
induced SNHL.
Our study showed that cleaved Caspase-1 and downstream
inflammatory factors including IL-1b and IL-18 were acti-
vated in CMV infected cochleae (Fig. 3). These Results indi-
cate that inflammasome assembling plays an important role inCMV induced hearing loss, which is related to initialization of
immune responses in the infected cochlea. The IL-18 activa-
tion is recently shown to involve AIM2 (Rathinam et al.,
2010), which binds its ligand DNA directly and engages
ASC to form a caspase-1-activating inflammasome
(Fernandes-Alnemri et al., 2009). Herein, we have also char-
acterized Aim2- Caspase-1 pathway as being crucial for innate
immunity to CMV in mouse cochlea (Fig. 4).
The possible signaling pathways that are involved in CMV
induced inner ear lesions in this mouse model are diagram-
matically illustrated in Fig. 5. Briefly, in addition to CMV
infection that may directly induce nervous system lesions
148 X. Shi et al. / Journal of Otology 10 (2015) 143e149affecting hearing, DNA sensor Aim2 engages ASC to form a
inflammasome and regulate caspase-1-dependent maturation
of IL-1b and IL-18, as well as downstream inflammation in
response to CMV infection in mouse cochlea. The persever-
ative inflammation can potentially result in tissue damage and
lead to SNHL.
In addition, the hypothesis on inflammasome playing a key
role in hearing lesions resulting from excessive immune re-
action is supported by another rare hearing disease e Muckle-
well syndrome (MWS), which is caused by a mutation in the
NLRP3 gene. The altered gene product cryopyrin leads to
activation of inflammasome which in turn is responsible for
excessive production of interleukin IL-1b. IL-1b causes the
inflammatory manifestations in MWS with progressive
sensorineural hearing loss (Kuemmerle-Deschner and Haug,
2013). Therefore, attenuating the activation of inflammasome
may be as a new strategy to control hearing impairment
induced by excessive immune responses. This strategy illu-
minates the need in treating CMV induced SNHL to suppress
persistent inflammatory state ignited by inflammasome, and to
control inflammation in order to avoid organ and other tissue
damage.
In summary, this study shows that inflammasome is
potentially a novel target for prevention and treatment of CMV
related SNHL. Combined with ganciclovir antiviral therapy,
other drugs (anakinra, for example) that affect cryopyrin
inflammasome and improve sensory deafness in patient with
Muckle-Wells syndrome (MWS) (Yamazaki et al., 2008) may
be recommended for clinical and laboratory manifestations of
CMV induced SNHL.
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